{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T18:57:17Z","timestamp":1760295437797,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1124\/jpet.106.101188","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T04:04:20Z","timestamp":1148443460000},"page":"1057-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of Original Dual Thromboxane A2 Modulators as Antiangiogenic Agents"],"prefix":"10.1016","volume":"318","author":[{"given":"Xavier","family":"de Leval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Dassesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Dogn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Waltregny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akeila","family":"Bellahc\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Pirotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Castronovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Ahmad S and Ahmed A (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95: 884\u2013891.","key":"10.1124\/jpet.106.101188_bib1","DOI":"10.1161\/01.RES.0000147365.86159.f5"},{"doi-asserted-by":"crossref","unstructured":"Arisato T, Hashiguchi T, Sarker KP, Arimura K, Asano M, Matsuo K, Osame M, and Maruyama I (2003) Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J Thromb Haemostasis 1: 2589\u20132593.","key":"10.1124\/jpet.106.101188_bib2","DOI":"10.1046\/j.1538-7836.2003.00475.x"},{"doi-asserted-by":"crossref","unstructured":"Bellahcene A, Bonjean K, Fohr B, Fedarko NS, Robey FA, Young MF, Fisher LW, and Castronovo V (2000) Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 86: 885\u2013891.","key":"10.1124\/jpet.106.101188_bib3","DOI":"10.1161\/01.RES.86.8.885"},{"doi-asserted-by":"crossref","unstructured":"Belton O, Byrne D, Kearney D, Leahy A, and Fitzgerald DJ (2000) Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102: 840\u2013845.","key":"10.1124\/jpet.106.101188_bib4","DOI":"10.1161\/01.CIR.102.8.840"},{"doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343: 1520\u20131528.","key":"10.1124\/jpet.106.101188_bib5","DOI":"10.1056\/NEJM200011233432103"},{"doi-asserted-by":"crossref","unstructured":"Born GV and Cross MJ (1963) The aggregation of blood platelets. J Physiol (Lond) 168: 178\u2013195.","key":"10.1124\/jpet.106.101188_bib6","DOI":"10.1113\/jphysiol.1963.sp007185"},{"doi-asserted-by":"crossref","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, et al. (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092\u20131102.","key":"10.1124\/jpet.106.101188_bib7","DOI":"10.1056\/NEJMoa050493"},{"doi-asserted-by":"crossref","unstructured":"Carty E, Rampton DS, Schneider H, Rutgeerts P, and Wright JP (2001) Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn\u2019s disease. Aliment Pharmacol Ther 15: 1323\u20131329.","key":"10.1124\/jpet.106.101188_bib8","DOI":"10.1046\/j.1365-2036.2001.01056.x"},{"doi-asserted-by":"crossref","unstructured":"Daniel TO, Liu H, Morrow JD, Crews BC, and Marnett LJ (1999) Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574\u20134577.","key":"10.1124\/jpet.106.101188_bib9","DOI":"10.1016\/S0090-6980(99)90300-3"},{"doi-asserted-by":"crossref","unstructured":"de Leval X, Delarge J, Devel P, Neven P, Michaux C, Masereel B, Pirotte B, David JL, Henrotin Y, and Dogn JM (2001) Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood. Prostaglandins Leukotrienes Essent Fatty Acids 64: 211\u2013216.","key":"10.1124\/jpet.106.101188_bib10","DOI":"10.1054\/plef.2001.0262"},{"doi-asserted-by":"crossref","unstructured":"de Leval X, Delarge J, Somers F, de Tullio P, Henrotin Y, Pirotte B, and Dogne JM (2000) Recent advances in inducible cyclooxygenase (COX-2) inhibition. Curr Med Chem 7: 1041\u20131062.","key":"10.1124\/jpet.106.101188_bib11","DOI":"10.2174\/0929867310007011041"},{"doi-asserted-by":"crossref","unstructured":"Dogne JM, de Leval X, Delarge J, David JL, and Masereel B (2000) New trends in thromboxane and prostacyclin modulators. Curr Med Chem 7: 609\u2013628.","key":"10.1124\/jpet.106.101188_bib12","DOI":"10.2174\/0929867003374868"},{"doi-asserted-by":"crossref","unstructured":"Dogne JM, de Leval X, Hanson J, Frederich M, Lambermont B, Ghuysen A, Casini A, Masereel B, Ruan KH, Pirotte B, et al. (2004) New developments on thromboxane and prostacyclin modulators. Part I: thromboxane modulators. Curr Med Chem 11: 1223\u20131241.","key":"10.1124\/jpet.106.101188_bib13","DOI":"10.2174\/0929867043365260"},{"doi-asserted-by":"crossref","unstructured":"Dogne JM, de Leval X, Kolh P, Sanna V, Rolin S, Michaux C, Mauer M, David JL, Masereel B, and Pirotte B (2003) Pharmacological evaluation of the novel thromboxane modulator BM-567 (I\/II). Effects of BM-567 on platelet function. Prostaglandins Leukotrienes Essent Fatty Acids 68: 49\u201354.","key":"10.1124\/jpet.106.101188_bib14","DOI":"10.1016\/S0952-3278(02)00236-3"},{"doi-asserted-by":"crossref","unstructured":"FitzGerald GA (2003) COX-2 and beyond: approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov 2: 879\u2013890.","key":"10.1124\/jpet.106.101188_bib15","DOI":"10.1038\/nrd1225"},{"doi-asserted-by":"crossref","unstructured":"Fortun PJ and Hawkey CJ (2005) Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 21: 169\u2013175.","key":"10.1124\/jpet.106.101188_bib16","DOI":"10.1097\/01.mog.0000153314.51198.58"},{"doi-asserted-by":"crossref","unstructured":"Fujimoto J, Sakaguchi H, Hirose R, Wen H, and Tamaya T (1999) Angiogenesis in endometriosis and angiogenic factors. Gynecol Obstet Invest 48 (Suppl 1): 14\u201320.","key":"10.1124\/jpet.106.101188_bib17","DOI":"10.1159\/000052864"},{"doi-asserted-by":"crossref","unstructured":"Gargiulo P, Giusti C, Pietrobono D, La Torre D, Diacono D, and Tamburrano G (2004) Diabetes mellitus and retinopathy. Dig Liver Dis 36 (Suppl 1): S101\u2013S105.","key":"10.1124\/jpet.106.101188_bib18","DOI":"10.1016\/j.dld.2003.11.016"},{"doi-asserted-by":"crossref","unstructured":"Gately S (2000) The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19: 19\u201327.","key":"10.1124\/jpet.106.101188_bib19","DOI":"10.1023\/A:1026575610124"},{"doi-asserted-by":"crossref","unstructured":"Gately S and Li WW (2004) Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31: 2\u201311.","key":"10.1124\/jpet.106.101188_bib20","DOI":"10.1053\/j.seminoncol.2004.03.040"},{"doi-asserted-by":"crossref","unstructured":"Joo YE, Kim HS, Min SW, Lee WS, Park CH, Park CS, Choi SK, Rew JS, and Kim SJ (2002) Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer 31: 147\u2013154.","key":"10.1124\/jpet.106.101188_bib21","DOI":"10.1385\/IJGC:31:1-3:147"},{"doi-asserted-by":"crossref","unstructured":"Jurasz P, Alonso-Escolano D, and Radomski MW (2004) Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819\u2013826.","key":"10.1124\/jpet.106.101188_bib22","DOI":"10.1038\/sj.bjp.0706013"},{"doi-asserted-by":"crossref","unstructured":"Kinsella BT (2001) Thromboxane A2 signalling in humans: a `tail\u2019 of two receptors. Biochem Soc Trans 29: 641\u2013654.","key":"10.1124\/jpet.106.101188_bib23","DOI":"10.1042\/bst0290641"},{"doi-asserted-by":"crossref","unstructured":"Kroll J, Shi X, Caprioli A, Liu HH, Waskow C, Lin KM, Miyazaki T, Rodewald HR, and Sato TN (2005) The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol Cell Biol 25: 8531\u20138540.","key":"10.1124\/jpet.106.101188_bib24","DOI":"10.1128\/MCB.25.19.8531-8540.2005"},{"doi-asserted-by":"crossref","unstructured":"LaMontagne K, Littlewood-Evans A, Schnell C, O\u2019Reilly T, Wyder L, Sanchez T, Probst B, Butler J, Wood A, Liau G, et al. (2006) Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 66: 221\u2013231.","key":"10.1124\/jpet.106.101188_bib25","DOI":"10.1158\/0008-5472.CAN-05-2001"},{"doi-asserted-by":"crossref","unstructured":"Leong TT, Fearon U, and Veale DJ (2005) Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis. Curr Rheumatol Rep 7: 325\u2013329.","key":"10.1124\/jpet.106.101188_bib26","DOI":"10.1007\/s11926-005-0044-5"},{"doi-asserted-by":"crossref","unstructured":"Marcus AJ, Broekman MJ, Weksler BB, Jaffe EA, Safier LB, Ullman HL, and Tack-Goldman K (1981) Interactions between stimulated platelets and endothelial cells in vitro. Philos Trans R Soc Lond B Biol Sci 294: 343\u2013353.","key":"10.1124\/jpet.106.101188_bib27","DOI":"10.1098\/rstb.1981.0111"},{"doi-asserted-by":"crossref","unstructured":"Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, Ghoneim MA, and Watson DK (2005) Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res 65: 11581\u201311587.","key":"10.1124\/jpet.106.101188_bib28","DOI":"10.1158\/0008-5472.CAN-05-1622"},{"unstructured":"Nicosia RF and Ottinetti A (1990) Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab Investig 63: 115\u2013122.","key":"10.1124\/jpet.106.101188_bib29"},{"doi-asserted-by":"crossref","unstructured":"Nie D, Che M, Zacharek A, Qiao Y, Li L, Li X, Lamberti M, Tang K, Cai Y, Guo Y, et al. (2004) Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am J Pathol 164: 429\u2013439.","key":"10.1124\/jpet.106.101188_bib30","DOI":"10.1016\/S0002-9440(10)63133-1"},{"doi-asserted-by":"crossref","unstructured":"Nie D, Lamberti M, Zacharek A, Li L, Szekeres K, Tang K, Chen Y, and Honn KV (2000) Thromboxane A2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 267: 245\u2013251.","key":"10.1124\/jpet.106.101188_bib31","DOI":"10.1006\/bbrc.1999.1840"},{"unstructured":"Pradono P, Tazawa R, Maemondo M, Tanaka M, Usui K, Saijo Y, Hagiwara K, and Nukiwa T (2002) Gene transfer of thromboxane A2 synthase and prostaglandin I2 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62: 63\u201366.","key":"10.1124\/jpet.106.101188_bib32"},{"doi-asserted-by":"crossref","unstructured":"Pratico D and Dogne JM (2005) Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine. Circulation 112: 1073\u20131079.","key":"10.1124\/jpet.106.101188_bib33","DOI":"10.1161\/CIRCULATIONAHA.104.524231"},{"doi-asserted-by":"crossref","unstructured":"Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, and Preissner KT (2004) The functional role of blood platelet components in angiogenesis. Thromb Haemost 92: 394\u2013402.","key":"10.1124\/jpet.106.101188_bib34","DOI":"10.1160\/TH03-04-0213"},{"doi-asserted-by":"crossref","unstructured":"Shukla N, Freeman N, Gadsdon P, Angelini GD, and Jeremy JY (2001) Thapsigargin inhibits angiogenesis in the rat isolated aorta: studies on the role of intracellular calcium pools. Cardiovasc Res 49: 681\u2013689.","key":"10.1124\/jpet.106.101188_bib35","DOI":"10.1016\/S0008-6363(00)00269-8"},{"doi-asserted-by":"crossref","unstructured":"Sinead M, Miggin SM, and Kinsella BT (2002) Regulation of extracellular signal-regulated kinase cascades by \u03b1and \u03b2-isoforms of the human thromboxane A2 receptor. Mol Pharmacol 61: 817\u2013831.","key":"10.1124\/jpet.106.101188_bib36","DOI":"10.1016\/S0026-895X(24)12333-4"},{"doi-asserted-by":"crossref","unstructured":"Uchida T, Kido H, Yamanaga K, Okita M, and Watanabe M (1992) A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery. Prostaglandins Leukotrienes Essent Fatty Acids 45: 121\u2013124.","key":"10.1124\/jpet.106.101188_bib37","DOI":"10.1016\/0952-3278(92)90227-A"},{"doi-asserted-by":"crossref","unstructured":"Vanchieri C (2004) Vioxx withdrawal alarms cancer prevention researchers. J Natl Cancer Inst 96: 1734\u20131735.","key":"10.1124\/jpet.106.101188_bib38","DOI":"10.1093\/jnci\/96.23.1734"},{"doi-asserted-by":"crossref","unstructured":"Walsh DA (1999) Angiogenesis and arthritis. Rheumatology (Oxford) 38: 103\u2013112.","key":"10.1124\/jpet.106.101188_bib39","DOI":"10.1093\/rheumatology\/38.2.103"},{"doi-asserted-by":"crossref","unstructured":"Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, and Xie K (2004) Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64: 2030\u20132038.","key":"10.1124\/jpet.106.101188_bib40","DOI":"10.1158\/0008-5472.CAN-03-1945"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524328794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524328794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.101188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:59:16Z","timestamp":1740002356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524328794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0022356524328794"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.101188","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Original Dual Thromboxane A2 Modulators as Antiangiogenic Agents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.101188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}